Condition
Chemsex
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting2
Not Yet Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07509853Not ApplicableRecruiting
Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand
NCT06980974Not ApplicableWithdrawnPrimary
Acceptance and Commitment Therapy for Chemsex
NCT06610916Not ApplicableNot Yet RecruitingPrimary
Faisability and Efficacity of the Reinforced Communautary Support Program (PARC) on the Complications of Chemsex
NCT05945199Not ApplicableRecruitingPrimary
Effectiveness of tDCS on Reducing Craving in Patients Practicing Chemsex: a Single-center, Double-blind, Randomized Controlled Pilot Trial
Showing all 4 trials